Immucor to Host Debt Investor Conference Call on Thursday, January 30, 2014 Print E-mail
By GLOBE NEWSWIRE   
Tuesday, 14 January 2014 07:58

NORCROSS, Ga., Jan. 14, 2014 (GLOBE NEWSWIRE)

NORCROSS, Ga., Jan. 14, 2014 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt investors on Thursday, January 30 at 10:00 a.m. ET to discuss its fiscal 2014 second quarter results.

Interested debt investors and analysts should contact Immucor Investor Relations at investor-requests@immucor.com or 770-441-2051 for details.

About Immucor

Founded in 1982, Immucor is a global leader in transfusion and transplantation diagnostics that facilitate patient-donor compatibility. Our mission is to ensure that patients in need of blood, organs or stem cells get the

Error. Page cannot be displayed. Please contact your service provider for more details. (16)

right match that is safe, accessible and affordable. With the right match, we can transform a life together. For more information on Immucor, please visit our website at www.immucor.com.

CONTACT: Michele Howard          770-441-2051



BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and
firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 

Newsletter

BMR:1